{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:42:37Z","timestamp":1787168557244,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212087"],"award-info":[{"award-number":["7212087"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2022YFF0710301"],"award-info":[{"award-number":["2022YFF0710301"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cca.2023.117531","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T18:25:03Z","timestamp":1693851903000},"page":"117531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Abnormal kynurenine-pathway metabolites in gout: Biomarkers exploration based on orthogonal partial least squares-discriminant analysis"],"prefix":"10.1016","volume":"549","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0825-6126","authenticated-orcid":false,"given":"Zhenni","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaerbanu","family":"Nizhamuding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6349","key":"10.1016\/j.cca.2023.117531_b0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cca.2023.117531_b0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cca.2023.117531_b0015","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbi.2023.04.015","article-title":"Correlations between kynurenines in plasma and CSF, and their relation to markers of Alzheimer's disease pathology","volume":"111","author":"Bakker","year":"2023","journal-title":"Brain Behav Immun"},{"issue":"2","key":"10.1016\/j.cca.2023.117531_b0020","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163472","article-title":"Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients","volume":"133","author":"Watne","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2023.117531_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104589","article-title":"CSF neopterin, quinolinic acid and kynurenine\/tryptophan ratio are biomarkers of active neuroinflammation","volume":"91","author":"Yan","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cca.2023.117531_b0030","article-title":"Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review","volume":"13","author":"Fathi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117531_b0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"7","key":"10.1016\/j.cca.2023.117531_b0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat Rev Neurosci"},{"issue":"32","key":"10.1016\/j.cca.2023.117531_b0045","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1523\/JNEUROSCI.1107-14.2014","article-title":"Reduction of brain kynurenic acid improves cognitive function","volume":"34","author":"Kozak","year":"2014","journal-title":"J Neurosci"},{"issue":"10-11","key":"10.1016\/j.cca.2023.117531_b0050","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1159\/000519811","article-title":"The Kynurenine pathway in acute kidney injury and chronic kidney disease","volume":"52","author":"Wee","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cca.2023.117531_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123953","article-title":"Neurological and inflammatory manifestations in sj\u00f6gren's syndrome: The role of the kynurenine metabolic pathway","volume":"19","author":"de Oliveira","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.cca.2023.117531_b0060","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.3390\/jcm10112484","article-title":"Crosstalk between tryptophan metabolism via kynurenine pathway and carbohydrate metabolism in the context of cardio-metabolic risk-review","volume":"10","author":"Kiluk","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.cca.2023.117531_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1318-5","article-title":"A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis","volume":"38","author":"Xiang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"17-18","key":"10.1016\/j.cca.2023.117531_b0070","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1101\/gad.327056.119","article-title":"MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer","volume":"33","author":"Venkateswaran","year":"2019","journal-title":"Genes Dev"},{"key":"10.1016\/j.cca.2023.117531_b0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1158\/2326-6066.CIR-19-0282","article-title":"Interferon-induced IDO1 mediates radiation resistance and is a therapeutic target in colorectal cancer","volume":"8","author":"Chen","year":"2020","journal-title":"Cancer Immunol Res."},{"key":"10.1016\/j.cca.2023.117531_b0080","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fimmu.2017.00880","article-title":"The IDO-AhR axis controls Th17\/Treg immunity in a pulmonary model of fungal infection","volume":"8","author":"de Ara\u00fajo","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117531_b0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fimmu.2015.00058","article-title":"The coevolution of IDO1 and AhR in the emergence of regulatory T-Cells in mammals","volume":"6","author":"Grohmann","year":"2015","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.cca.2023.117531_b0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jmv.25083","article-title":"The role of IDO, IL-10, and TGF-\u03b2 in the HCV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma","volume":"91","author":"Yang","year":"2019","journal-title":"J Med Virol"},{"issue":"19-20","key":"10.1016\/j.cca.2023.117531_b0095","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1007\/s00018-007-7140-9","article-title":"Tryptophan degradation in autoimmune diseases","volume":"64","author":"Opitz","year":"2007","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.cca.2023.117531_b0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cca.2023.117531_b0105","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-12-0014","article-title":"IDO is a nodal pathogenic driver of lung cancer and metastasis development","volume":"2","author":"Smith","year":"2012","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.cca.2023.117531_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"issue":"10055","key":"10.1016\/j.cca.2023.117531_b0115","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cca.2023.117531_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166374","article-title":"Kidney and plasma metabolomics provide insights into the molecular mechanisms of urate nephropathy in a mouse model of hyperuricemia","volume":"1868","author":"Li","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.cca.2023.117531_b0125","unstructured":"CLSI. C-62A: Liquid chromatography-mass spectrometry methods; approved guideline. Wayne, PA: Clinical and Laboratory Standards Institute;2014."},{"key":"10.1016\/j.cca.2023.117531_b0130","article-title":"Gout: diagnosis and management-summary of NICE guidance","volume":"378","author":"Neilson","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2023.117531_b0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2288-1-11","article-title":"Sample size requirements for case-control study designs","volume":"1","author":"Edwardes","year":"2001","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cca.2023.117531_b0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.11604\/pamj.2022.42.180.34264","article-title":"Role of plasma homocysteine levels and other associated factors with coronary artery disease among Palestinian patients in North Palestine: a case control study","volume":"42","author":"Alawneh","year":"2022","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.cca.2023.117531_b0145","unstructured":"CLSI. EP28-A3c: Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline - Third edition. Wayne, PA: Clinical and Laboratory Standards Institute;2010."},{"key":"10.1016\/j.cca.2023.117531_b0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cca.2022.09.019","article-title":"The establishment of LC-MS\/MS assays-specific reference intervals for serum folates and its application in evaluating FA-supplemented folate deficiency patients: Appeals for a suitable and individualized supplementation","volume":"537","author":"Liu","year":"2022","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2023.117531_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113246","article-title":"A validated UHPLC-MS method for tryptophan metabolites: Application in the diagnosis of multiple sclerosis","volume":"185","author":"T\u00f6m\u00f6si","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cca.2023.117531_b0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","article-title":"Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options","volume":"15","author":"Bardin","year":"2017","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.cca.2023.117531_b0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41584-021-00657-4","article-title":"Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities","volume":"17","author":"Stamp","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.cca.2023.117531_b0170","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ndt\/gfn739","article-title":"Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms","volume":"24","author":"Schefold","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.cca.2023.117531_b0175","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/1535370217693114","article-title":"The activation of the kynurenine pathway in a rat model with renovascular hypertension","volume":"242","author":"Bartosiewicz","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.cca.2023.117531_b0180","article-title":"Kynurenine pathway metabolites as potential clinical biomarkers in coronary artery disease","volume":"12","author":"G\u00e1sp\u00e1r","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117531_b0185","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2174\/0929867321666140304105526","article-title":"Disturbed tryptophan metabolism in cardiovascular disease","volume":"21","author":"Mangge","year":"2014","journal-title":"Curr Med Chem"},{"issue":"16","key":"10.1016\/j.cca.2023.117531_b0190","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00018-017-2504-2","article-title":"Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases","volume":"74","author":"Song","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.cca.2023.117531_b0195","article-title":"Kynurenine promotes neonatal heart regeneration by stimulating cardiomyocyte proliferation and cardiac angiogenesis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.cca.2023.117531_b0200","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12035-015-9232-0","article-title":"Increased plasma levels of xanthurenic and kynurenic acids in Type 2 diabetes","volume":"52","author":"Oxenkrug","year":"2015","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.cca.2023.117531_b0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/0929867328666210714153649","article-title":"Tryptophan Metabolism in Atherosclerosis and Diabetes","volume":"29","author":"Sudar-Milovanovic","year":"2022","journal-title":"Curr Med Chem"},{"issue":"3","key":"10.1016\/j.cca.2023.117531_b0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/met.2017.0097","article-title":"Dysregulation of tryptophan catabolism in metabolic syndrome","volume":"16","author":"Mallmann","year":"2018","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"10.1016\/j.cca.2023.117531_b0215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clim.2005.03.009","article-title":"Serum neopterin for early assessment of severity of severe acute respiratory syndrome","volume":"116","author":"Zheng","year":"2005","journal-title":"Clin Immunol"},{"issue":"0","key":"10.1016\/j.cca.2023.117531_b0220","article-title":"Neopterin and kynurenine in serum and urine as prognostic biomarkers in hospitalized patients with delta and omicron variant SARS-CoV-2 infection","volume":"0","author":"Kr\u010dmov\u00e1","year":"2023","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"10.1016\/j.cca.2023.117531_b0225","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1038\/s41380-022-01552-4","article-title":"The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments","volume":"27","author":"Almulla","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.cca.2023.117531_b0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-0841-5","article-title":"Increased urinary excretion of kynurenic acid is associated with non-recovery from acute kidney injury in critically ill patients","volume":"19","author":"Aregger","year":"2018","journal-title":"BMC Nephrol"},{"issue":"7","key":"10.1016\/j.cca.2023.117531_b0235","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/ph14070606","article-title":"Kynurenines as a novel target for the treatment of malignancies","volume":"14","author":"Mor","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"13","key":"10.1016\/j.cca.2023.117531_b0240","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: An overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.cca.2023.117531_b0245","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"10.1016\/j.cca.2023.117531_b0250","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","article-title":"\u03b2-Hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares","volume":"18","author":"Goldberg","year":"2017","journal-title":"Cell Rep"},{"issue":"10287","key":"10.1016\/j.cca.2023.117531_b0255","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Gout. Lancet"},{"issue":"1","key":"10.1016\/j.cca.2023.117531_b0260","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7555","article-title":"Xanthine oxidoreductase regulates macrophage IL1\u03b2 secretion upon NLRP3 inflammasome activation","volume":"6","author":"Ives","year":"2015","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.cca.2023.117531_b0265","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jchromb.2009.01.015","article-title":"Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC-tandem mass spectrometry","volume":"877","author":"de Jong","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.cca.2023.117531_b0270","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/clinchem\/44.4.858","article-title":"Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients","volume":"44","author":"Huengsberg","year":"1998","journal-title":"Clin Chem"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123003339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123003339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:09:36Z","timestamp":1757862576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123003339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":54,"alternative-id":["S0009898123003339"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117531","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal kynurenine-pathway metabolites in gout: Biomarkers exploration based on orthogonal partial least squares-discriminant analysis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117531"}}